Literature DB >> 15845321

Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).

Shane Darke1, Anna Williamson, Joanne Ross, Maree Teesson.   

Abstract

A cohort of 495 heroin users, recruited for the Australian Treatment Outcome Study (ATOS), were re-interviewed at 12 months regarding suicide attempts over the follow-up period. The proportion who had attempted suicide in the 12 months since baseline was not significantly different from that reported in the 12 months preceding ATOS enrolment (12.2% versus 9.1%), and attempted suicide did not decline significantly in any of the index treatment groups. Among males, there was no significant reduction in attempted suicide (8.7% versus 8.1%). Among females, however, the proportion reporting an attempt declined significantly from 19.7 to 9.8%. Of those who reported suicidal ideation at baseline, 22.8% made an attempt over the follow-up period, as did 19.0% of those who had major depression. Large, and significant, declines in suicidal ideation (23.1% versus 6.9%) and major depression (25.5% versus 10.9%) occurred over the study period. Independent predictors of a suicide attempt over the follow-up period were: social isolation, having made an attempt in the preceding 12 months, suicidal ideation at baseline, a greater number of treatment episodes and higher levels of baseline polydrug use.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15845321     DOI: 10.1016/j.drugalcdep.2004.10.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  16 in total

1.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

2.  The Role of Gender in Suicidal Ideation among Long-term Opioid Users.

Authors:  Kirsten Marchand; Heather Palis; Jill Fikowski; Scott Harrison; Patricia Spittal; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Can J Psychiatry       Date:  2017-05-18       Impact factor: 4.356

3.  Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence.

Authors:  Fiona L Shand; Louisa Degenhardt; Tim Slade; Elliot C Nelson
Journal:  Addict Behav       Date:  2010-08-10       Impact factor: 3.913

4.  Suicide attempts within 12 months of treatment for substance use disorders.

Authors:  Peter C Britton; Kenneth R Conner
Journal:  Suicide Life Threat Behav       Date:  2010-02

Review 5.  Anxiety and its disorders as risk factors for suicidal thoughts and behaviors: A meta-analytic review.

Authors:  Kate H Bentley; Joseph C Franklin; Jessica D Ribeiro; Evan M Kleiman; Kathryn R Fox; Matthew K Nock
Journal:  Clin Psychol Rev       Date:  2015-12-02

6.  Test of a clinical model of drinking and suicidal risk.

Authors:  Kenneth R Conner; Douglas Gunzler; Wan Tang; Xin M Tu; Stephen A Maisto
Journal:  Alcohol Clin Exp Res       Date:  2010-10-19       Impact factor: 3.455

7.  Trait mindfulness, reasons for living and general symptom severity as predictors of suicide probability in males with substance abuse or dependence.

Authors:  Parvaneh Mohammadkhani; Hamid Khanipour; Hedieh Azadmehr; Ardeshir Mobramm; Esmaeil Naseri
Journal:  Iran J Psychiatry       Date:  2015

Review 8.  Neuropsychological Functions of μ- and δ-Opioid Systems.

Authors:  Anna G Polunina; Evgeny A Bryun
Journal:  ISRN Addict       Date:  2013-12-26

9.  Predictors of suicide attempters in substance-dependent patients: a six-year prospective follow-up.

Authors:  Kjell Bakken; Per Vaglum
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-10-10

10.  Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.

Authors:  Perrine Roux; Caroline Lions; Laurent Michel; Marion Mora; Jean-Pierre Daulouède; Fabienne Marcellin; Bruno Spire; Alain Morel; Patrizia M Carrieri
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.